ASD与ADHD诊断年份相关的遗传风险变化
该队列研究基于丹麦iPSYCH2015数据,分析1994至2016年ASD和ADHD发病诊断者的多基因风险评分随诊断年份的变化。结果显示诊断年份越近,ADHD和ASD的遗传风险评分越低,提示诊断标准放宽可能是发病率上升的解释之一。
要点
- ADHD诊断每晚10年,ADHD多基因评分平均低0.06个标准差。
- ASD诊断每晚10年,ASD多基因评分平均低0.07个标准差。
- 诊断年份越近,多种精神疾病和认知行为特质的多基因评分也越低。
核心结论
- 诊断年份越近的ADHD和ASD个体其遗传风险评分越低,支持诊断标准放宽解释发病率上升。
研究设计与样本
- 基于丹麦iPSYCH2015人群病例队列研究,纳入1994至2016年ASD和ADHD发病诊断者。
临床怎么用
- 临床解读ASD和ADHD发病率上升时需考虑诊断标准变化对遗传风险构成的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The incidences of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) have increased markedly over recent decades, raising concerns about the emergence of new risk factors. Current literature typically attributes increased rates to changes in diagnostic practice, stigmatization, and awareness, but critically few studies have explored changes in underlying risk factors. OBJECTIVE: To assess changes in the genetic risk profile of individuals diagnosed with ASD or ADHD by year of incident diagnosis and explore results in comparison with those expected under simulated scenarios. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH2015) study, a population-based case-cohort in Denmark among individuals with incident diagnoses for ASD and ADHD made from 1994 to 2016. Data were analyzed from January 2024 until September 2025. EXPOSURE: Year of incident diagnosis. Regression models tested changes in the mean genetic risk profile of individuals diagnosed in each consecutive year (1994-2016), adjusting for age, sex, and ancestry. MAIN OUTCOMES: Polygenic scores for psychiatric (ADHD, ASD, depression, bipolar, and schizophrenia) and cognitive-behavioral (addiction, educational attainment, IQ, neuroticism, and risk-taking) outcomes were used to capture genetic risk profiles of diagnosed individuals. Empirical trends were compared with those expected under different simulated drivers of increasing rates. RESULTS: A total of 17 071 individuals with incident diagnoses for ASD (4196 female [24.6%]; mean [SD] age at diagnosis, 9.7 [4.6] years) and 20 111 with diagnoses for ADHD (5960 female [29.6%]; mean [SD] age at diagnosis, 11.0 ([4.7] years) were analyzed. A more recent ADHD diagnosis was associated with decreased genetic risk for ADHD as shown by difference in mean polygenic score (β estimate per 10-year increase, -0.06 SDs; 95% CI, -0.09 to -0.03 SDs; P = .001) and other disorders, including ASD, bipolar, and schizophrenia (eg, ASD: β per 10-year increase, -0.07 SDs; 95% CI, -0.10 to -0.03 SDs; P < .001). Similarly, a more recent ASD diagnosis was associated with decreased genetic risk for ASD (β per 10-year increase, -0.07 SDs; 95% CI, -0.10 to -0.04 SDs; P < .001) and other disorders and traits, including bipolar disorder, schizophrenia, and educational attainment (eg, bipolar disorder: β per 10-year increase, -0.05 SDs; 95% CI, -0.08 to -0.02 SDs; P = .001). CONCLUSIONS AND RELEVANCE: By analyzing multiple polygenic scores together with simulated expectations, this study could disambiguate among competing hypotheses about scenarios that may be associated with increased rates of ADHD and ASD diagnoses. Findings support broadening diagnostic criteria as an explanation for increasing rates, with implications for understanding changes in risk factors and clinical practice.
引用
- LaBianca S, Lousdal ML, Dybdahl Krebs M, et al. Changes in Genetic Contributions to ASD and ADHD by Year of Diagnosis. JAMA Psychiatry. 2026. PMID: 42268594. doi:10.1001/jamapsychiatry.2026.1450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。